JP2020536519A5 - - Google Patents

Download PDF

Info

Publication number
JP2020536519A5
JP2020536519A5 JP2020517799A JP2020517799A JP2020536519A5 JP 2020536519 A5 JP2020536519 A5 JP 2020536519A5 JP 2020517799 A JP2020517799 A JP 2020517799A JP 2020517799 A JP2020517799 A JP 2020517799A JP 2020536519 A5 JP2020536519 A5 JP 2020536519A5
Authority
JP
Japan
Prior art keywords
promoter
nucleotide sequence
sequence encoding
construct according
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020517799A
Other languages
English (en)
Japanese (ja)
Other versions
JP7240749B2 (ja
JP2020536519A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2018/011521 external-priority patent/WO2019066548A2/ko
Publication of JP2020536519A publication Critical patent/JP2020536519A/ja
Publication of JP2020536519A5 publication Critical patent/JP2020536519A5/ja
Application granted granted Critical
Publication of JP7240749B2 publication Critical patent/JP7240749B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020517799A 2017-09-29 2018-09-28 心不全の予防または治療のための医薬組成物 Active JP7240749B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2017-0127442 2017-09-29
KR20170127442 2017-09-29
PCT/KR2018/011521 WO2019066548A2 (ko) 2017-09-29 2018-09-28 심부전의 예방 또는 치료용 약학적 조성물

Publications (3)

Publication Number Publication Date
JP2020536519A JP2020536519A (ja) 2020-12-17
JP2020536519A5 true JP2020536519A5 (https=) 2021-11-04
JP7240749B2 JP7240749B2 (ja) 2023-03-16

Family

ID=65902613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020517799A Active JP7240749B2 (ja) 2017-09-29 2018-09-28 心不全の予防または治療のための医薬組成物

Country Status (6)

Country Link
US (1) US12215362B2 (https=)
EP (1) EP3690054B1 (https=)
JP (1) JP7240749B2 (https=)
KR (1) KR102712841B1 (https=)
CN (1) CN111465697B (https=)
WO (1) WO2019066548A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2953301B2 (es) * 2023-09-25 2024-06-03 Univ Madrid Complutense Péptido para el tratamiento de enfermedades cardiacas

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US20090239940A1 (en) 1997-07-22 2009-09-24 Del Monte Federica Treating heart failure and ventricular arrhythmias
DK1027437T3 (da) * 1997-10-29 2008-11-24 Genentech Inc Anvendelse af det WNT-1 inducerede udskilte polypeptid WISP-1
EP1783228A1 (en) * 2005-11-08 2007-05-09 ETH Zürich Recombinant expression of multiprotein complexes using polygenes
KR101187814B1 (ko) * 2010-03-22 2012-10-08 광주과학기술원 심부전 예방 또는 치료용 약제학적 조성물 및 심부전 예방 또는 치료제의 스크리닝 방법
US20180099029A9 (en) * 2010-04-15 2018-04-12 Mount Sinai School Of Medicine Serca2 therapeutic compositions and methods of use
CA2841548A1 (en) * 2011-07-13 2013-01-17 Icahn School Of Medicine At Mount Sinai Sumoylation of serca2a and cardiovascular disease
FI3536797T3 (fi) * 2013-02-01 2023-03-23 Selexis Sa Siirtogeenin tehostettu ilmentäminen ja prosessointi
EP3204503A1 (en) * 2014-10-06 2017-08-16 Arthrogen BV Aav-based gene therapy
SG11201803934YA (en) * 2015-11-11 2018-06-28 Intrexon Corp Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
ES2943391T3 (es) * 2015-11-13 2023-06-13 Bethphagen Inc Proteína CCN5 para el tratamiento de una enfermedad cardíaca asociada con la distrofia muscular de Duchenne
EP3689363A4 (en) * 2017-09-29 2021-05-19 BethphaGen Inc. PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CARDIAC ARRHYTHMIA

Similar Documents

Publication Publication Date Title
JP7707261B2 (ja) 筋疾患の治療のための改変ａａｖカプシドポリペプチド
ES2387082T3 (es) Uso de OSTEOPONTINA para el tratamiento y/o prevención de enfermedades neurológicas
JP2020518268A5 (https=)
JP2020073536A5 (https=)
US20240002462A1 (en) Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs
JP2001520238A (ja) 低毒性のヒトインターフェロン−αアナログ
RU2019126509A (ru) Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе
JP2023535121A5 (https=)
JP2023509118A5 (https=)
JP2024545183A5 (https=)
JP2021533801A5 (https=)
JP2024545186A5 (https=)
JP2020527167A5 (https=)
JP2020535203A5 (https=)
JP2020536519A5 (https=)
US11510999B2 (en) Treatment of neuropathy with DNA constructs expressing IGF-1 isoforms
US20150118187A1 (en) Micro-organs providing sustained delivery of a therapeutic polypeptide and methods of use thereof
RU2639582C2 (ru) Композиция для предупреждения или лечения бокового амиотрофического склероза с использованием двух или более изоформ фактора роста гепатоцитов
ES2234714T3 (es) Interferon beta para el tratamiento de enfermedades inmunes.
CN107073078B (zh) 利用肝细胞生长因子和基质细胞衍生因子1α的用于预防或治疗外周动脉疾病的组合物
RU2020114946A (ru) Фармацевтическая композиция для профилактики или лечения аритмии сердца
RU2020114942A (ru) Фармацевтическая композиция для профилактики или лечения сердечной недостаточности
JP2021506283A (ja) ハイブリッドｈｇｆ遺伝子が導入されたａａｖ（アデノ−関連ウイルス）ベクター
TW202337476A (zh) 用於與肌肉萎縮蛋白有關之心肌病之基因療法組合物及治療
ES3006614T3 (en) Relaxin receptor 1 for use in treatment and prevention of heart failure